Curbing the tuberculosis and diabetes co-epidemic

Bao, J., Hafner, R., Lin, Y., Lin, H.H. and Magee, M.J., 2018. Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and research. The International Journal of Tuberculosis and Lung Disease, 22(10), pp.1111-1112.

  • Progress in reducing TB incidence and mortality has been slow.
  • TB control strategies are being threatened by diabetes mellitus (DM), a non-communicable disease.
  • DM increases the risk of developing active TB.
  • The prevalence of DM has risen most quickly in low- and middle-income regions with significant TB burdens.
  • Current estimates suggest DM contributes to as many cases of active TB as HIV/AIDS.
  • The DM epidemic continues to increase steadily.
  • Patients with both TB and DM experience worse clinical outcomes, including increased risk of treatment failure, relapse, and death.
  • Resources for TB-DM research and treatment programs are limited.
  • Large-scale clinical trials have not been conducted to find better treatment and management methods for patients with concurrent TB and DM.


    Popular posts from this blog

    Health system delay among patients with TB in Taiwan

    The effect of type 2 DM on the presentation and treatment response of pulmonary TB

    Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis